144 related articles for article (PubMed ID: 36823311)
1. The tumor biological significance of RNF43 and LRP1B in gastric cancer is complex and context-dependent.
Holm B; Barsuhn S; Behrens HM; Krüger S; Röcken C
Sci Rep; 2023 Feb; 13(1):3191. PubMed ID: 36823311
[TBL] [Abstract][Full Text] [Related]
2. Loss of endogenous RNF43 function enhances proliferation and tumour growth of intestinal and gastric cells.
Neumeyer V; Grandl M; Dietl A; Brutau-Abia A; Allgäuer M; Kalali B; Zhang Y; Pan KF; Steiger K; Vieth M; Anton M; Mejías-Luque R; Gerhard M
Carcinogenesis; 2019 Jun; 40(4):551-559. PubMed ID: 30380024
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of LDL receptor-related protein 1B in patients with gastric cancer.
Yasufuku I; Saigo C; Kito Y; Yoshida K; Takeuchi T
J Mol Histol; 2021 Apr; 52(2):165-172. PubMed ID: 33389427
[TBL] [Abstract][Full Text] [Related]
4. Frequent frameshift mutations in 2 mononucleotide repeats of RNF43 gene and its regional heterogeneity in gastric and colorectal cancers.
Jo YS; Kim MS; Lee JH; Lee SH; An CH; Yoo NJ
Hum Pathol; 2015 Nov; 46(11):1640-6. PubMed ID: 26297255
[TBL] [Abstract][Full Text] [Related]
5. Loss of RNF43 Function Contributes to Gastric Carcinogenesis by Impairing DNA Damage Response.
Neumeyer V; Brutau-Abia A; Allgäuer M; Pfarr N; Weichert W; Falkeis-Veits C; Kremmer E; Vieth M; Gerhard M; Mejías-Luque R
Cell Mol Gastroenterol Hepatol; 2021; 11(4):1071-1094. PubMed ID: 33188943
[TBL] [Abstract][Full Text] [Related]
6. Ring finger protein 43 associates with gastric cancer progression and attenuates the stemness of gastric cancer stem-like cells via the Wnt-β/catenin signaling pathway.
Gao Y; Cai A; Xi H; Li J; Xu W; Zhang Y; Zhang K; Cui J; Wu X; Wei B; Chen L
Stem Cell Res Ther; 2017 Apr; 8(1):98. PubMed ID: 28446252
[TBL] [Abstract][Full Text] [Related]
7. Different effects of p53 protein overexpression on the survival of gastric cancer patients according to Lauren histologic classification: a retrospective study.
Kim KW; Kim N; Choi Y; Kim WS; Yoon H; Shin CM; Park YS; Lee DH; Park YS; Ahn SH; Park DJ; Kim HH; Lee HS; Kim JW; Kim JW; Lee KW; Chang W; Park JH; Lee YJ; Lee KH; Kim YH
Gastric Cancer; 2021 Jul; 24(4):844-857. PubMed ID: 33598811
[TBL] [Abstract][Full Text] [Related]
8. RNF43 mutation is associated with aggressive tumor biology along with BRAF V600E mutation in right-sided colorectal cancer.
Matsumoto A; Shimada Y; Nakano M; Oyanagi H; Tajima Y; Nakano M; Kameyama H; Hirose Y; Ichikawa H; Nagahashi M; Nogami H; Maruyama S; Takii Y; Ling Y; Okuda S; Wakai T
Oncol Rep; 2020 Jun; 43(6):1853-1862. PubMed ID: 32236609
[TBL] [Abstract][Full Text] [Related]
9. The Intestinal Stem Cell Marker SMOC2 Is an Independent Prognostic Marker Associated With Better Survival in Gastric Cancer.
Hyun CL; Park SJ; Kim HS; Song HJ; Kim HU; Lee C; Lee DH; Maeng YH; Kim YS; Jang B
Anticancer Res; 2021 Jul; 41(7):3689-3698. PubMed ID: 34230168
[TBL] [Abstract][Full Text] [Related]
10. Impact of loss-of-function mutations at the RNF43 locus on colorectal cancer development and progression.
Eto T; Miyake K; Nosho K; Ohmuraya M; Imamura Y; Arima K; Kanno S; Fu L; Kiyozumi Y; Izumi D; Sugihara H; Hiyoshi Y; Miyamoto Y; Sawayama H; Iwatsuki M; Baba Y; Yoshida N; Furukawa T; Araki K; Baba H; Ishimoto T
J Pathol; 2018 Aug; 245(4):445-455. PubMed ID: 29756208
[TBL] [Abstract][Full Text] [Related]
11. FGFR2 overexpression and compromised survival in diffuse-type gastric cancer in a large central European cohort.
Schrumpf T; Behrens HM; Haag J; Krüger S; Röcken C
PLoS One; 2022; 17(2):e0264011. PubMed ID: 35167603
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of leucine-rich-repeat-containing G-protein-coupled receptor 5, an intestinal stem cell marker, in gastric carcinomas.
Jang BG; Lee BL; Kim WH
Gastric Cancer; 2016 Jul; 19(3):767-77. PubMed ID: 26386561
[TBL] [Abstract][Full Text] [Related]
13. eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants.
Thornton AM; Fang L; Lo A; McSharry M; Haan D; O'Brien C; Berger AH; Giannakis M; Brooks AN
PLoS Comput Biol; 2021 Jul; 17(7):e1009132. PubMed ID: 34214079
[TBL] [Abstract][Full Text] [Related]
14. Dysregulated Wnt signalling and recurrent mutations of the tumour suppressor RNF43 in early gastric carcinogenesis.
Min BH; Hwang J; Kim NK; Park G; Kang SY; Ahn S; Ahn S; Ha SY; Lee YK; Kushima R; Van Vrancken M; Kim MJ; Park C; Park HY; Chae J; Jang SS; Kim SJ; Kim YH; Kim JI; Kim KM
J Pathol; 2016 Nov; 240(3):304-314. PubMed ID: 27514024
[TBL] [Abstract][Full Text] [Related]
15. p53 immunostaining cannot be used to predict TP53 mutations in gastric cancer: results from a large Central European cohort.
Schoop I; Maleki SS; Behrens HM; Krüger S; Haag J; Röcken C
Hum Pathol; 2020 Nov; 105():53-66. PubMed ID: 32971129
[TBL] [Abstract][Full Text] [Related]
16. Screening and clinical significance of lymph node metastasis-related genes within esophagogastric junction adenocarcinoma.
Han R; Chen G; Li M; Peng ZM; Xu L
Cancer Med; 2021 Aug; 10(15):5088-5100. PubMed ID: 34152098
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of tumour budding assessed in gastric carcinoma according to the criteria of the International Tumour Budding Consensus Conference.
Ulase D; Heckl S; Behrens HM; Krüger S; Röcken C
Histopathology; 2020 Feb; 76(3):433-446. PubMed ID: 31538348
[TBL] [Abstract][Full Text] [Related]
18. Protease associated domain of RNF43 is not necessary for the suppression of Wnt/β-catenin signaling in human cells.
Radaszkiewicz T; Bryja V
Cell Commun Signal; 2020 Jun; 18(1):91. PubMed ID: 32527265
[TBL] [Abstract][Full Text] [Related]
19. Expression of the potential therapeutic target claudin-18.2 is frequently decreased in gastric cancer: results from a large Caucasian cohort study.
Dottermusch M; Krüger S; Behrens HM; Halske C; Röcken C
Virchows Arch; 2019 Nov; 475(5):563-571. PubMed ID: 31332522
[TBL] [Abstract][Full Text] [Related]
20. Poor efficacy response to trastuzumab therapy in advanced gastric cancer with homogeneous HER2 positive and non-intestinal type.
Xu C; Liu Y; Jiang D; Li Q; Ge X; Zhang Y; Huang J; Su J; Ji Y; Hou J; Lu S; Hou Y; Liu T
Oncotarget; 2017 May; 8(20):33185-33196. PubMed ID: 28388541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]